| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/31/2009 | CA2506298C Conjugated fatty acid based emulsion and methods for preparing and using same |
| 03/31/2009 | CA2466654C Compositions comprising chitosan in the form of nano-sized fibres |
| 03/31/2009 | CA2356959C Water-insoluble drug delivery system |
| 03/31/2009 | CA2339792C Opthalmic solution with tetracycline for topical treatment of dry eye disease |
| 03/31/2009 | CA2317582C A drug dosage form based on the teorell-meyer gradient |
| 03/31/2009 | CA2193627C Subcutaneous implant |
| 03/26/2009 | WO2009039226A1 Lyophilized pharmaceutical compositions |
| 03/26/2009 | WO2009038779A2 Methods and compositions for inhibiting undesirable cellular proliferation by targeted liposome delivery of active agents |
| 03/26/2009 | WO2009038701A2 Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same |
| 03/26/2009 | WO2009038605A2 Flexible, polyvalent antiviral dendridic conjugates for the treatment of hiv/aids and enveloped viral infection |
| 03/26/2009 | WO2009038591A1 Bile salt colloids and methods of making and using thereof |
| 03/26/2009 | WO2009038217A1 Calcium secondary phosphate anhydride particle and method for producing the same |
| 03/26/2009 | WO2009038145A1 Method of producing granules containing material of natural origin such as chinese orthodox medicine extract, crude drug extract, natural material extract or mixture thereof and method of producing tablets from the granules |
| 03/26/2009 | WO2009038112A1 Solid preparation comprising npyy5 receptor antagonist |
| 03/26/2009 | WO2009038008A1 Process for producing fine particles and the fine particles |
| 03/26/2009 | WO2009037855A1 Oral and skin compositions |
| 03/26/2009 | WO2009037813A1 Transdermally absorbable preparation |
| 03/26/2009 | WO2009037525A1 Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and use thereof |
| 03/26/2009 | WO2009037401A1 System for controlled release of an active principle and method for preparation |
| 03/26/2009 | WO2009037061A2 Use of hydrophobin polypeptides as penetration enhancers |
| 03/26/2009 | WO2009036933A2 Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles |
| 03/26/2009 | WO2009001209A8 Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases |
| 03/26/2009 | WO2008151235A3 Compositions for delivering medicaments into the lungs, uses thereof |
| 03/26/2009 | WO2008145943A3 Vehicle in the form of a water-in-oil emulsion in particular for ophthalmic or dermocosmetic use |
| 03/26/2009 | WO2008074488A3 Construction and use of transfection enhancer elements |
| 03/26/2009 | WO2005018486A3 Use of melatonin-containing oral supplement with animals |
| 03/26/2009 | WO2005010141A3 Compositions for purifying and crystallizing molecules of interest |
| 03/26/2009 | WO2005004813A3 Botanical extract compositions and process for preparing same |
| 03/26/2009 | US20090082550 Antibody compositions and methods |
| 03/26/2009 | US20090082549 Sequence encoding amino acids 301-437 of the Fc region of the mouse immunoglobulin e molecule is genetically fused to pseudomonas exotoxin |
| 03/26/2009 | US20090082547 Compositions for enhancing transport of molecules into cells |
| 03/26/2009 | US20090082466 Solid oral dosage forms of opioid agonist painkiller, one or more of polyethylene glycol mono- or distearates, water insoluble waxes, glycerol monostearate or hydrogenated vegetable oil; tamper resistant dosage form; prevent or minimizing excessive peak concentrations when taken with alcohol |
| 03/26/2009 | US20090082460 Polyamide-Polyether Block Copolymer |
| 03/26/2009 | US20090082275 Ob protein compositions and methods |
| 03/26/2009 | US20090082255 by addition of surfactants providing a high long-term stability due to stress; storage stability to hydrophobic aggregation nuclei for several months under temperature stress; for the treatment of diabetes; FDA Orange book listed patent for insulin glargine recombinant |
| 03/26/2009 | US20090081791 Intracellular delivery of small molecules, proteins, and nucleic acids |
| 03/26/2009 | US20090081660 Compositions and methods for the diagnosis and treatment of tumor |
| 03/26/2009 | US20090081635 Modified heparinase iii and methods of sequencing therewith |
| 03/26/2009 | US20090081322 Process for the preparation of antioxidant conserve from Indian curry leaves (MURRAYA KOENIGII SPRENG.) |
| 03/26/2009 | US20090081309 Stabilized Oral Suspension Formulation |
| 03/26/2009 | US20090081308 Anhdyrous lactose agglomerates and the preparation thereof |
| 03/26/2009 | US20090081302 Pulmonary delivery of polyene antifungal agents |
| 03/26/2009 | US20090081294 Sustained release dosage form for lubricating an oral cavity |
| 03/26/2009 | US20090081292 Oil-containing solid product and process for producing the same |
| 03/26/2009 | US20090081290 Tamper resistant dosage forms |
| 03/26/2009 | US20090081277 Pharmaceutical formulations and methods for treating ocular conditions |
| 03/26/2009 | US20090081276 Bioresorbable implant composition |
| 03/26/2009 | US20090081249 Bi-Functional Polymer-Attached Inhibitors of Influenza Virus |
| 03/26/2009 | US20090081247 Immune adjuvant comprising ATP |
| 03/26/2009 | US20090081209 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins |
| 03/26/2009 | US20090081180 Antimicrobial polymer conjugates |
| 03/26/2009 | US20090081150 Cyclopropanated macrocyclic ketones and lactones |
| 03/26/2009 | US20090081139 Water-based delivery systems |
| 03/26/2009 | US20090081133 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulations |
| 03/26/2009 | US20090081130 Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream |
| 03/26/2009 | US20090078315 Electrode, method of making same, photoelectric transfer element, method of manufacturing same, electronic device and method of manufacturing same |
| 03/26/2009 | CA2700224A1 Method of producing granules containing natural products derived substance such as chinese orthodox medicine extracts, crude drug extracts, and extracts derived from natural substances, and producing a tablet in use of said granules |
| 03/26/2009 | CA2699944A1 Targeted interferon demonstrates potent apoptotic and anti-tumor activities |
| 03/26/2009 | CA2699761A1 Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same |
| 03/26/2009 | CA2699638A1 Down-regulation of the gene expression by means of nucleic acid-loaded virus-like particles |
| 03/26/2009 | CA2699394A1 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
| 03/26/2009 | CA2698293A1 Use of hydrophobin polypeptides as penetration intensifiers |
| 03/26/2009 | CA2696914A1 Lyophilized pharmaceutical compositions |
| 03/26/2009 | CA2696634A1 Monoclonal antibodies against human acidic and basic ferritins and nucleotide and amino acid sequences thereof |
| 03/26/2009 | CA2693912A1 System for controlled release of an active principle and method for preparation |
| 03/25/2009 | EP2039761A1 Influenza vaccine composition |
| 03/25/2009 | EP2039370A1 Ophthalmic composition for soft contact lens comprising terpenoid |
| 03/25/2009 | EP2039358A1 Pharmaceutical compositions comprising a macrolide and an acid |
| 03/25/2009 | EP2039353A1 Reduced coenzyme q10-containing composition and method for producing the same |
| 03/25/2009 | EP2038302A2 Immunotoxins for the treatment of diseases related to cmv infection |
| 03/25/2009 | EP2037974A2 Use of gelatin and a cross-linking agent for producing a cross-linking therapeutic composition |
| 03/25/2009 | EP2037966A2 Sialoadhesin-related compositions and methods |
| 03/25/2009 | EP2037897A2 An oral pharmaceutical composition of an anilinopyrimidine, its preparation and use thereof |
| 03/25/2009 | EP2037891A1 Tablets comprising candesartan cilexetil |
| 03/25/2009 | EP2037883A2 Inhalant powder containing phenylalanine |
| 03/25/2009 | EP2000152A9 Solid preparation having improved solubility |
| 03/25/2009 | EP2000150A9 Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle |
| 03/25/2009 | EP1846445B1 Pyy agonists and uses thereof |
| 03/25/2009 | EP1681280B1 Novel phenol derivatives and antitrypanosoma preventive/therapeutic agent containing the same as active ingredient |
| 03/25/2009 | EP1668062B1 Telechelic homopolyamino acids functionalized by hydrophobic groups and uses, particularly therapeutic, thereof |
| 03/25/2009 | EP1594523B1 Pharmaceutical compositions comprising botulinum toxin and human serum albumin |
| 03/25/2009 | EP1583713B1 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 03/25/2009 | EP1565206B1 Novel use of erythropoietin in heart diseases |
| 03/25/2009 | EP1543063B1 Drug delivery |
| 03/25/2009 | EP1509201B1 Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof |
| 03/25/2009 | EP1504010B1 Vitamin-mitomycin conjugates |
| 03/25/2009 | EP1492452A4 System, formulation, kit and method for tagging colonic residue in an individual |
| 03/25/2009 | EP1238282B1 Methods of diagnosis and treatment by binding p75/airm1 |
| 03/25/2009 | EP1154770B1 Parenteral formulation of piperacillin |
| 03/25/2009 | EP1119335B1 Capsules and a process for making the same |
| 03/25/2009 | EP1053010B1 Copolymer compositions for oral delivery |
| 03/25/2009 | EP1050301B1 Medicinal compositions containing 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol |
| 03/25/2009 | CN201211389Y Chemical reaction vapor pressure type intestines and stomach drug releasing device suitable for ultrasonic trigger control |
| 03/25/2009 | CN101395168A Galactose derivative,Drug carrier and medicinal composition |
| 03/25/2009 | CN101394867A Process for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants |
| 03/25/2009 | CN101394866A Stabilizer for hydrophobic compounds |
| 03/25/2009 | CN101394836A Medicament containing fluoroquinolones |
| 03/25/2009 | CN101394753A Method for improving affinity of sparingly soluble or insoluble substance in solvent using water-soluble xylan |
| 03/25/2009 | CN101392034A Dextran-phosphatidyl ethanolamine polymer micelle and preparation method thereof |
| 03/25/2009 | CN101391103A Medicine composition for preventing and treating AIDS viral infection |